TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
IRTC

iRhythm Technologies Inc

Healthcare · Medical Devices

111.80$ -0.1% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns iRhythm Technologies Inc (IRTC)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 91.9% of the shares are freely tradable; institutional investors hold 111.1%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 111.1%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 1.2%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 91.9%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 8.5%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 33Mio.

Largest Shareholders

Institutions

Institutions IRTC
Name Stake (%) Shares Change (%) Date
BlackRock Inc 8.32 2,741,505 -2.6 03/31/2026
Vanguard Portfolio Management, LLC 5.45 1,796,372 +0.0 03/31/2026
RTW INVESTMENTS, LLC 5.06 1,668,500 +41.2 03/31/2026
Artisan Partners Limited Partnership 5.04 1,660,307 +14.4 06/30/2026
Vanguard Capital Management, LLC 4.39 1,445,710 +0.0 03/31/2026
Millennium Management LLC 4.27 1,406,454 -12.5 06/30/2026
FMR Inc 4.13 1,361,919 +116.6 03/31/2026
Holocene Advisors, LP 3.79 1,248,658 +82.7 03/31/2026
UBS Asset Mgmt Americas Inc 3.18 1,047,452 +26.2 03/31/2026

Funds

Funds IRTC
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 3.13 1,030,699 +0.4 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings IRTC
Person Role Shares Value As of Type
Blackford Quentin S. President and CEO 226,008 25,267,694 $ Aug 10, 2026 direct
Murphy Patrick Michael CBO and CLO 69,699 7,792,348 $ Aug 10, 2026 direct
Patterson Chad CHIEF COMM & PRODUCT OFFICER 62,125 6,945,575 $ Aug 10, 2026 direct
Turakhia Minang CHIEF MED/SCI OFCR EVP ADVTECH 60,116 6,720,969 $ Aug 10, 2026 direct
Shrishrimal Sumi EVP, Chief Risk Officer 44,621 4,988,628 $ Aug 10, 2026 direct
Wilson Daniel G. Chief Financial Officer 34,887 3,900,367 $ Sep 2, 2026 direct
Smith Mervin EVP Strategic Business Ops 22,410 2,505,438 $ Aug 3, 2026 direct
Rodda Julianne EVP, CHIEF PEOPLE OFFICER 18,201 2,034,872 $ Aug 3, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Sep 2, 2026 Wilson Daniel G. Chief Financial Officer Sell 773 121.83 94,175
Aug 10, 2026 Turakhia Minang CHIEF MED/SCI OFCR EVP ADVTECH Sell 7,093 124.65 884,151
Aug 10, 2026 Shrishrimal Sumi EVP, Chief Risk Officer Sell 5,372 124.65 669,641
Aug 10, 2026 Patterson Chad CHIEF COMM & PRODUCT OFFICER Sell 7,093 124.65 884,170
Aug 10, 2026 Murphy Patrick Michael CBO and CLO Sell 7,093 124.65 884,156
Aug 10, 2026 Blackford Quentin S. President and CEO Sell 26,859 124.65 3,348,012
Aug 7, 2026 Turakhia Minang CHIEF MED/SCI OFCR EVP ADVTECH Other 13,589 0.00
Aug 7, 2026 Shrishrimal Sumi EVP, Chief Risk Officer Other 9,706 0.00
Aug 7, 2026 Patterson Chad CHIEF COMM & PRODUCT OFFICER Other 13,589 0.00
Aug 7, 2026 Murphy Patrick Michael CBO and CLO Other 13,589 0.00
Aug 7, 2026 Blackford Quentin S. President and CEO Other 48,534 0.00
Aug 3, 2026 Rodda Julianne EVP, CHIEF PEOPLE OFFICER Sell 2,112 122.12 257,919
Aug 3, 2026 Smith Mervin EVP Strategic Business Ops Sell 617 122.12 75,349
Aug 3, 2026 Patterson Chad CHIEF COMM & PRODUCT OFFICER Sell 2,712 122.12 331,192

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?